Drug Makers, Indian Regulators Design Plan For Fixed-Dose Phase-out
This article was originally published in PharmAsia News
Executive Summary
Indian drug makers and government regulators have designed a formula for determining which of 294 fixed-dose combination dugs are to be phased out of the market. The Confederation of Indian Pharmaceutical Industry reached an agreement with the government to have the industry cease production and marketing of 11 drugs on the government's ban list. The CIPI then is to conduct a product-by-product examination of the drugs for safety and efficacy. (Click here for more